Dr. Mohamed Yousry Elgendi, Assistant Professor of Biomedical Engineering and Biotechnology at Khalifa University, has been appointed to the editorial board of Communications Medicine and selected to serve as an ambassador for the Nature Portfolio journal.
As an editorial board member, Dr. Elgendi will work closely with the journal’s in-house editors, handle manuscripts within his areas of expertise, oversee the peer-review process, support scientific quality and integrity, and help maintain high standards for research accepted for publication. According to Scopus data accessed in August 2026, Communications Medicine ranks in the 95th percentile and is ranked first among 11 journals in the Assessment and Diagnosis category.
In his additional role as a journal ambassador, Dr. Elgendi will help strengthen engagement between Communications Medicine and the international research community, promote the dissemination of high-quality clinical and translational research, and support the journal’s global outreach.
The appointment recognizes Dr. Elgendi’s expertise in artificial intelligence-driven digital medicine, biomedical sensing, wearable and contactless health technologies, physiological signal processing, and health data analytics. His research at Khalifa University integrates artificial intelligence, physiological sensing and digital biomarkers to advance cardiovascular monitoring, remote patient assessment and precision digital health.
Dr. Elgendi has authored more than 170 scientific publications and has been recognized as one of the world’s top 2% of scientists in the global citation-impact database developed by Stanford University researchers since 2021. His work has contributed to advances in photoplethysmography, wearable biosensing, remote physiological monitoring, cuffless cardiovascular assessment and machine-learning-enabled healthcare technologies.
Before joining Khalifa University, Dr. Elgendi held research and leadership positions at ETH Zurich, the University of British Columbia, the University of Alberta and Nanyang Technological University. His research has supported international collaborations across academia, healthcare and industry, contributing to advances in digital medicine and the translation of AI-enabled physiological monitoring systems into healthcare applications.
Dr. Elgendi has also supervised and mentored more than 60 undergraduate and postgraduate researchers. Many of these researchers have subsequently pursued opportunities at internationally recognized institutions, including MIT, Harvard University, Columbia University, the University of Pennsylvania, ETH Zurich, Carnegie Mellon University and the University of Melbourne.
Dr. Elgendi said: “I am honored to join the editorial board of Communications Medicine and serve as an ambassador for the journal. These roles reflect Khalifa University’s growing international leadership in biomedical innovation and digital medicine. I look forward to working with the journal’s editors and international research community to uphold scientific rigor, strengthen global engagement and support the translation of innovative discoveries into meaningful improvements in healthcare and patient outcomes.”
The appointment further strengthens Khalifa University’s international visibility in AI-enabled biomedical innovation and digital medicine while supporting its commitment to research excellence and global scientific collaboration.
